Patent directory · USPTO A61K / A61P
Patents matching “INTEGRATED BIOTHERAPEUTICS, INC.”
9 pharma patents match "INTEGRATED BIOTHERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 9 pharmaceutical patents matching "INTEGRATED BIOTHERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11186626
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
granted -
US 11135280
Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity
granted -
US 11028153
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
granted -
US 10611827
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins
granted -
US 10487140
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
granted -
US 10174085
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
granted -
US 10023848
Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides
granted -
US 9815872
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
granted -
US 9109036
Immunogenic composition comprising alpha-hemolysin oligopeptides
granted